{"id":"https://openalex.org/W7166188854","doi":"https://doi.org/10.1021/acs.jmedchem.6c00540","title":"Antibody-Assisted Protection from Paraoxon and Nerve Agent Model Compounds","display_name":"Antibody-Assisted Protection from Paraoxon and Nerve Agent Model Compounds","publication_year":2026,"publication_date":"2026-06-26","ids":{"openalex":"https://openalex.org/W7166188854","doi":"https://doi.org/10.1021/acs.jmedchem.6c00540","pmid":"https://pubmed.ncbi.nlm.nih.gov/42360194"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.6c00540","doi":"https://doi.org/10.1021/acs.jmedchem.6c00540","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.6c00540","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083255756","display_name":"Charles M. Thompson","orcid":"https://orcid.org/0000-0003-0018-4973","observed_orcids":["https://orcid.org/0000-0003-0018-4973"]},"institutions":[{"id":"https://openalex.org/I4210110847","display_name":"Human BioMolecular Research Institute","ror":"https://ror.org/018m20m74","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210110847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles M. Thompson","raw_affiliation_strings":["Human BioMolecular Research Institute, 6351 Nancy Ridge Drive, Suite B, San Diego, California 92121, United States"],"raw_orcid":"https://orcid.org/0000-0003-0018-4973","affiliations":[{"raw_affiliation_string":"Human BioMolecular Research Institute, 6351 Nancy Ridge Drive, Suite B, San Diego, California 92121, United States","institution_ids":["https://openalex.org/I4210110847"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057134151","display_name":"Jorge Gomez\u2010Galeno","orcid":"https://orcid.org/0000-0002-4662-9002","observed_orcids":["https://orcid.org/0000-0002-4662-9002"]},"institutions":[{"id":"https://openalex.org/I4210110847","display_name":"Human BioMolecular Research Institute","ror":"https://ror.org/018m20m74","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210110847"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jorge Gomez-Galeno","raw_affiliation_strings":["Human BioMolecular Research Institute, 6351 Nancy Ridge Drive, Suite B, San Diego, California 92121, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Human BioMolecular Research Institute, 6351 Nancy Ridge Drive, Suite B, San Diego, California 92121, United States","institution_ids":["https://openalex.org/I4210110847"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028469156","display_name":"John Richard Cashman","orcid":"https://orcid.org/0000-0002-8628-9129","observed_orcids":["https://orcid.org/0000-0002-8628-9129"]},"institutions":[{"id":"https://openalex.org/I4210110847","display_name":"Human BioMolecular Research Institute","ror":"https://ror.org/018m20m74","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210110847"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"John R. Cashman","raw_affiliation_strings":["Human BioMolecular Research Institute, 6351 Nancy Ridge Drive, Suite B, San Diego, California 92121, United States"],"raw_orcid":"https://orcid.org/0000-0002-8628-9129","affiliations":[{"raw_affiliation_string":"Human BioMolecular Research Institute, 6351 Nancy Ridge Drive, Suite B, San Diego, California 92121, United States","institution_ids":["https://openalex.org/I4210110847"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5028469156"],"corresponding_institution_ids":["https://openalex.org/I4210110847"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"69","issue":"13","first_page":"15581","last_page":"15596"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.492900013923645,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.492900013923645,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10875","display_name":"Pesticide Exposure and Toxicity","score":0.40139999985694885,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.034699998795986176,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/organophosphorus-compounds","display_name":"organophosphorus compounds","score":0.8149999976158142},{"id":"https://openalex.org/keywords/paraoxon","display_name":"paraoxon","score":0.9829999804496765},{"id":"https://openalex.org/keywords/nerve-agents","display_name":"nerve agents","score":0.9380000233650208},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9449999928474426},{"id":"https://openalex.org/keywords/acetylcholinesterase-inhibition","display_name":"acetylcholinesterase inhibition","score":0.8930000066757202},{"id":"https://openalex.org/keywords/organophosphate-hydrolysis","display_name":"organophosphate hydrolysis","score":0.6639999747276306},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.6100000143051147},{"id":"https://openalex.org/keywords/chemical-warfare-agent-decontamination","display_name":"chemical warfare agent decontamination","score":0.578000009059906}],"concepts":[{"id":"https://openalex.org/C2777207434","wikidata":"https://www.wikidata.org/wiki/Q416108","display_name":"Paraoxon","level":4,"score":0.9628000259399414},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9315999746322632},{"id":"https://openalex.org/C2778706303","wikidata":"https://www.wikidata.org/wiki/Q2612896","display_name":"Nerve agent","level":4,"score":0.9212999939918518},{"id":"https://openalex.org/C2778816929","wikidata":"https://www.wikidata.org/wiki/Q22676679","display_name":"Acetylcholinesterase","level":3,"score":0.7609000205993652},{"id":"https://openalex.org/C29144244","wikidata":"https://www.wikidata.org/wiki/Q506441","display_name":"Hapten","level":3,"score":0.5684999823570251},{"id":"https://openalex.org/C2780266723","wikidata":"https://www.wikidata.org/wiki/Q408044","display_name":"Soman","level":4,"score":0.5454000234603882},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.536899983882904},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5336999893188477},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.47920000553131104},{"id":"https://openalex.org/C2779059548","wikidata":"https://www.wikidata.org/wiki/Q383701","display_name":"Ach\u00e9","level":4,"score":0.46619999408721924},{"id":"https://openalex.org/C2780358027","wikidata":"https://www.wikidata.org/wiki/Q407752","display_name":"Neurotoxin","level":2,"score":0.4059999883174896},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.31839999556541443},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.301800012588501},{"id":"https://openalex.org/C94412978","wikidata":"https://www.wikidata.org/wiki/Q103135","display_name":"Hydrolysis","level":2,"score":0.3003999888896942},{"id":"https://openalex.org/C80107235","wikidata":"https://www.wikidata.org/wiki/Q7162625","display_name":"Penetration (warfare)","level":2,"score":0.2994000017642975},{"id":"https://openalex.org/C53270655","wikidata":"https://www.wikidata.org/wiki/Q5381536","display_name":"Enzymatic hydrolysis","level":3,"score":0.2985000014305115},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.2883000075817108},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.28769999742507935},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.27619999647140503},{"id":"https://openalex.org/C2776588719","wikidata":"https://www.wikidata.org/wiki/Q411097","display_name":"Organophosphate","level":3,"score":0.26759999990463257},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.25940001010894775}],"mesh":[{"descriptor_ui":"D000067397","descriptor_name":"Nerve Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000067397","descriptor_name":"Nerve Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D000067397","descriptor_name":"Nerve Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D002800","descriptor_name":"Cholinesterase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002801","descriptor_name":"Cholinesterase Reactivators","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002801","descriptor_name":"Cholinesterase Reactivators","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006241","descriptor_name":"Haptens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006241","descriptor_name":"Haptens","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006868","descriptor_name":"Hydrolysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010261","descriptor_name":"Paraoxon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010261","descriptor_name":"Paraoxon","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D010261","descriptor_name":"Paraoxon","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D011220","descriptor_name":"Pralidoxime Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011220","descriptor_name":"Pralidoxime Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.jmedchem.6c00540","doi":"https://doi.org/10.1021/acs.jmedchem.6c00540","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.6c00540","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:42360194","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42360194","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4012186343","display_name":"Novel Antibody-Oxime Pairing to Reduce Circulating Organophosphate Levels.","funder_award_id":"U01NS112108","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":63,"referenced_works":["https://openalex.org/W184605302","https://openalex.org/W1020594397","https://openalex.org/W1572953732","https://openalex.org/W1590652959","https://openalex.org/W1966305477","https://openalex.org/W1967092932","https://openalex.org/W1971253356","https://openalex.org/W1977215955","https://openalex.org/W1984831910","https://openalex.org/W1989488731","https://openalex.org/W1989573513","https://openalex.org/W1996111288","https://openalex.org/W1996507395","https://openalex.org/W1999358494","https://openalex.org/W2008517042","https://openalex.org/W2021879064","https://openalex.org/W2024296350","https://openalex.org/W2025094509","https://openalex.org/W2025816743","https://openalex.org/W2029669944","https://openalex.org/W2031901496","https://openalex.org/W2037926632","https://openalex.org/W2043100521","https://openalex.org/W2043645233","https://openalex.org/W2048650475","https://openalex.org/W2049060580","https://openalex.org/W2050312480","https://openalex.org/W2051773944","https://openalex.org/W2060313254","https://openalex.org/W2061775251","https://openalex.org/W2065959195","https://openalex.org/W2066404087","https://openalex.org/W2071644440","https://openalex.org/W2074473216","https://openalex.org/W2082129175","https://openalex.org/W2085961489","https://openalex.org/W2088669541","https://openalex.org/W2103509572","https://openalex.org/W2105580021","https://openalex.org/W2137015675","https://openalex.org/W2145053300","https://openalex.org/W2153707560","https://openalex.org/W2154792548","https://openalex.org/W2155420406","https://openalex.org/W2161483353","https://openalex.org/W2165259978","https://openalex.org/W2166208491","https://openalex.org/W2279647745","https://openalex.org/W2283958510","https://openalex.org/W2344483747","https://openalex.org/W2495333157","https://openalex.org/W2577459782","https://openalex.org/W2619496385","https://openalex.org/W2790505995","https://openalex.org/W2884070261","https://openalex.org/W3027168038","https://openalex.org/W3088169631","https://openalex.org/W3159177617","https://openalex.org/W4248158572","https://openalex.org/W4253316735","https://openalex.org/W4366998330","https://openalex.org/W4378714914","https://openalex.org/W4387241684"],"related_works":["https://openalex.org/W2343866984","https://openalex.org/W2518977034","https://openalex.org/W1138875475","https://openalex.org/W2073184928","https://openalex.org/W6983814043","https://openalex.org/W2523437211","https://openalex.org/W100681284","https://openalex.org/W3174327266","https://openalex.org/W1978891441","https://openalex.org/W2080420301"],"abstract_inverted_index":{"A":[0],"key":[1],"challenge":[2],"in":[3,24,106],"organophosphorus":[4],"(OP)":[5],"research":[6],"is":[7],"to":[8,12,49,130,148],"develop":[9],"efficient":[10],"means":[11],"decrease":[13,37,149],"OP":[14,28,58],"levels":[15],"after":[16],"exposure.":[17],"Scavenging,":[18],"capturing,":[19],"or":[20,71],"degrading":[21],"circulating":[22],"OPs":[23,39,139],"vivo":[25],"could":[26,143],"minimize":[27],"penetration":[29],"into":[30],"the":[31,61,107,112],"brain":[32],"and":[33,36,69,100,117,134,137],"other":[34],"organs,":[35],"toxicity.":[38,151],"produce":[40],"acute":[41],"effects":[42],"primarily":[43],"through":[44],"acetylcholinesterase":[45],"(AChE)":[46],"inhibition,":[47],"leading":[48],"neurotoxic":[50],"events.":[51],"Current":[52],"standard":[53],"of":[54,109,114,120,126],"care":[55],"(SOC)":[56],"for":[57],"exposure":[59],"includes":[60],"AChE":[62,78],"reactivator":[63],"2-PAM":[64,133],"as":[65,67],"well":[66],"atropine,":[68],"midazolam":[70],"diazepam.":[72],"However,":[73],"SOC":[74,86],"therapeutics":[75],"only":[76],"address":[77],"symptomatic":[79],"toxicity":[80],"but":[81],"do":[82],"not":[83,88],"increase":[84],"clearance.":[85],"does":[87],"degrade":[89,138],"OPs.":[90],"Using":[91],"haptens":[92],"designed":[93],"employing":[94],"transition":[95],"state":[96],"analogy,":[97],"we":[98],"procured":[99],"characterized":[101],"monoclonal":[102],"antibodies":[103,129],"(mAbs)":[104],"that,":[105],"presence":[108],"2-PAM,":[110],"increased":[111],"hydrolysis":[113],"paraoxon":[115],"(POX)":[116],"promoted":[118],"degradation":[119],"nerve":[121],"agent":[122],"mimics.":[123],"The":[124],"ability":[125],"these":[127],"novel":[128],"combine":[131],"with":[132],"selectively":[135],"recognize":[136],"suggests":[140],"that":[141],"they":[142],"provide":[144],"a":[145],"new":[146],"approach":[147],"OP-induced":[150]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2026-06-27T00:00:00"}